SCHEMBL8645752

SCHEMBL8645752

CCCCOc1cc2ncnc(N3CCc4ccc(Cl)cc43)c2cc1OC

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.62
CSF1R P07333 1/20 0.61
KDR P35968 8/20 0.51
RET P07949 2/20 0.51
KIF5B P33176 1/20 0.51
ACHE P22303 2/20 0.49
BACE1 P56817 2/20 0.49
KIT P10721 1/20 0.48
ENPP1 P22413 1/20 0.47
FGFR1 P11362 6/20 0.47
FLT1 P17948 6/20 0.47
FLT4 P35916 5/20 0.47
PDGFRB P09619 2/20 0.46
PDE1B Q01064 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8649000 0.91 EGFR (0.73) EGFRCSF1RKDRRETKIF5B
SCHEMBL9115449 0.88 EGFR (0.58) EGFRCSF1RKDRRETKIF5B
SCHEMBL8652546 0.88 EGFR (0.56) EGFRCSF1RKDRRETKIF5B
SCHEMBL8657810 0.87 EGFR (0.58) EGFRCSF1RKDRRETKIF5B
SCHEMBL8647397 0.87 EGFR (0.57) EGFRCSF1RKDRRETKIF5B
SCHEMBL9115373 0.86 EGFR (0.56) EGFRCSF1RKDRRETKIF5B
SCHEMBL8647215 0.86 EGFR (0.56) EGFRCSF1RKDRRETKIF5B
SCHEMBL9052816 0.85 EGFR (0.66) EGFRCSF1RKDRRETKIF5B
SCHEMBL8649983 0.85 EGFR (0.64) EGFRCSF1RKDRRETKIF5B
SCHEMBL9114206 0.84 EGFR (0.59) EGFRCSF1RKDRRETKIF5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5736534-A HYPERPROLIFERATIVE DISEASES; INHIBITORS OF PROTEIN-TYROSINE KINASES SUCH AS EPIDERMAL GROWTH FACTOR RECEPTOR; BRAIN, LUNG, BREAST CANCER; PSORIASIS AND BENIGN PROSTATE HYPERPLASIA PFIZER INC. (US) 1998-04-07 US disclosed
EP-0746554-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1996-12-11 EP disclosed
WO-1995023141-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1995-08-31 WO disclosed